Laying the Foundations of Pharmacare in Canada
Canada is the only developed country with a universal healthcare system, but no universal access to reimbursable medicines. This could change for the first time in the country's history if proposals by the Liberal government of Prime Minister Justin Trudeau for the creation of a publicly funded national prescription drug plan known as Pharmacare are implemented.
Watch our analyst, Margaret Labban, talk about the issue.
- China’s young biosimilars sector
- Polish pharma associations unite in appeal for greater access to biologics
- How to democratize access and prevent the next supermodel medicine
- Risks to UK pharmaceutical spending from a US-UK free trade deal
- Challenges with risk sharing in Eastern Europe raised at ISPOR Europe meeting
- Germany’s fixed pricing for medicines faces European reckoning
- Dynamic reform in International Reference Pricing
- Ten-year Medicare budget impact of increased coverage for anti-obesity intervention
China’s young biosimilars market is taking off, with a raft of approvals of domestically-developed biosimilars expe… https://t.co/9ONykEElmS
New originator biologics are being added to the reimbursement list in Poland, but they are simply not reaching a su… https://t.co/TLK722uAOe